Human gene
KRT5 keratin 5
1 disease group in OMIA reaches this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 2081 | Epidermolysis bullosa simplex, KRT5-related | domestic cattle | KRT5 | one to one | Target evidence |
61.9
|
| 2081 | Epidermolysis bullosa simplex, KRT5-related | Rhesus monkey | KRT5 | one to one | Target evidence |
61.9
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| epidermolysis bullosa simplex 2C, localized | MONDO:0030527 | 0.77 | 55 |
| epidermolysis bullosa simplex 2A, generalized severe | MONDO:0030489 | 0.76 | 37 |
| epidermolysis bullosa simplex 2B, generalized intermediate | MONDO:0030525 | 0.76 | 38 |
| epidermolysis bullosa simplex 2F, with mottled pigmentation | MONDO:0007556 | 0.73 | 21 |
| Dowling-Degos disease 1 | MONDO:0024534 | 0.70 | 47 |
| epidermolysis bullosa simplex 2d, generalized, intermediate or severe, autosomal recessive | MONDO:0030535 | 0.69 | 19 |
| epidermolysis bullosa simplex 2E, with migratory circinate erythema | MONDO:0012258 | 0.65 | 16 |
Drugs
Each ChEMBL drug that acts on this gene.
No ChEMBL drug acts on this gene, among the genes with target evidence.